One of the early dreams of the human genome project was the goal of personalized medicine. The vision was that each individual would have a compact disk containing their own unique DNA sequence, guiding myriad decisions on lifestyle, disease prevention, treatment and conceivably even career choice. At present, DNA sequencing technology is nowhere near cheap enough or fast enough to allow this dream. Nevertheless, genotyping technologies have made dramatic strides over the last decade, and these technologies may now be fast enough to allow interrogation of all relevant disease alleles in any given individual. The feasibility of this approach depends critically on the allelic structure of human disease genes. If all 30 000 genes make important contributions to disease susceptibility, and there are 1000 alleles for each gene, then a total of 3 Â 10 7 genotypings will have to be reliably performed-a daunting prospect. However, if only 1000 genes make appreciable contributions to human disease, and each of these genes has only 4 relevant alleles, then the number of genotypings to be performed is only 4000-highly feasible. In this review, we look at the present knowledge on the allelic complexity of human disease genes, as well as providing a brief glance to the future.
PROPERTIES OF ALLELIC SPACE
A perhaps oversimplified aid to visualizing the properties of human disease genes is provided in Figure 1 . This figure depicts a three-dimensional allelic space, with the axes of disease frequency, number of responsible loci and mean number of alleles at each locus. Regarding the second axis, number of responsible loci, genetic traits are traditionally divided into monogenic (single gene or simple trait), polygenic (many genes), and multifactorial or complex (interactions between multiple genes and environment). Because a single locus is responsible for the monogenic disorders, identification of the relevant loci is usually straightforward, provided that a sufficient number of multiplex families are available. In contrast, the genetics of complex traits remains murky, and success in identifying the responsible loci has been elusive. This is because many genes and environment conspire together in a series of complicated epistatic and synergistic relationships to cause the final disease phenotype. In general, the number of loci identified through linkage for any given complex disease trait is less than 10, but linkage can be expected to identify only the major contributing loci. Since, with very few exceptions, the genes responsible for complex traits have yet to be identified, it remains an open question as to the number of alleles at each locus.
Two extreme models are usually envisaged for complex disease traits ( Fig. 1) (1). One idea is that common alleles at a handful of loci interact to cause disease. This is referred to as the interaction model or the common disease/common variant (CD/CV) hypothesis. The competing notion is that rare alleles at numerous loci can each single-handedly cause the disease. This is referred to as the genetic heterogeneity model. Two other extreme models are also formally possible: complex disease traits are caused by a small number of loci each with a large number of alleles, or they are caused by a large number of loci with a large number of alleles (Fig. 1) . One of these last two alternatives (a small number of loci each with a large number of alleles) is rendered unlikely by considerations of human population structure (see below).
However, between the remaining three extremes, complex disease traits could occupy any middle ground.
INFERENCES FROM HUMAN POPULATION STRUCTURE
Reich and Lander (2) have provided a simple framework for understanding the allelic spectra (number and frequency of disease-predisposing alleles) of human disease genes. In addition, this work provides some justification for the CD/CV hypothesis.
There is a large amount of evidence suggesting a dramatic expansion of the human population $ 18 000-150 000 years or 700-6000 generations ago. This resulted in an increased effective population size from 10 4 individuals to the present size of 6 Â 10 9 . Assume expansion of one allele of a rare Figure 1 . Allelic space. This three-dimensional space provides an aid to visualizing possible structures of polymorphism for human disease genes. For monogenic disorders, rare diseases (green bar) have complex allelic spectra (high number of alleles per locus), while common diseases (yellow bar) have simple spectra (low number of alleles per locus). Special cases (gray bar) exist in situations such as heterozygous advantage and population bottlenecks. For common complex disease traits, the situation is less clear. Two extreme models are the interaction model (CD/CV hypothesis, dark blue bar) and the genetic heterogeneity model (red bar). However, two other extreme models are also formally possible: a small number of loci each with a large number of alleles (cyan bar), and a large number of loci each with a large number of alleles (magenta bar). Considerations of human population genetics (2) suggest that one of the four extreme models, a small number of loci each with a large number of alleles (cyan bar), is unlikely. However, present data are insufficient to confidently place complex disease traits between the remaining three extremes, indicated by the two-dimensional gray surface. In this figure, the following examples are employed (2, 10): monogenic (rare)-retinoblastoma; monogenic (common)-glucose-6-phosphate dehydrogenase deficiency (South China); monogenic (special case)-b-thalassemia (Sardinia); complex (interaction model)-Alzheimer's disease (speculative); complex (genetic heterogeneity model)-colon cancer (speculative). No known examples yet exist for the two hypothetical cases of common complex diseases caused by a small number of loci each with a large number of alleles or a large number of loci each with a large number of alleles. For clarity, the disease frequencies for both the monogenic and common complex disorders have been rounded to 10 À1 , but all are within one order of magnitude of the known frequency. In the cases of the complex diseases, Alzheimer's disease and colon cancer, the assigned values for the number of loci and the number of alleles per locus are highly speculative. For the purposes of the figure, it has been assumed that Alzheimer's disease is an example of the interaction model, whereas colon cancer is an example of the genetic heterogeneity model. Although both assumptions are conjectural, there is some evidence in favor of the genetic heterogeneity model for cancer (10) . Figure 2 . Human population structure. (A) A dramatic population expansion leads to increased numbers of individuals with a single allele of a rare (5 squares) and common (25 circles) disease gene. Because the rare disease gene is under strong negative selection, three alleles disappear in the population, and are replaced by three new alleles. Thus, only 2/5 (40%) of alleles represent the ancestral allele. In contrast, the common disease gene is under much less strong negative selection, and only one allele is lost to be replaced by three new alleles. The proportion of ancestral alleles is hence 24/27 (89%). Consequently, the common disease gene has a much simpler allelic structure in the present population than the rare gene. (B) Graphical depiction of (A). The population expansion leads to proportionate increases of a single allele of a common disease gene (red) and a rare disease gene (blue). In the present human population, the rapid loss of alleles and smaller population reservoir of the rare disease gene has lead to the allelic spectrum of this gene becoming relatively much more diverse than the common gene. However, in the far distant future (at equilibrium), the common disease gene can be expected to catch up with the rare gene, and the allelic spectra of both genes will be equally diverse. disease gene, and one allele of a common gene ( Fig. 2A) . With some notable exceptions, the available evidence suggests fairly similar mutation rates for most genes, $10 À6 -10 À5 per gene per generation (3-7). For the rare disease, the number of individuals in the expanded population is still small, and hence in relative terms they are quickly swamped by newly mutated alleles. In contrast, the population reservoir for the common disease gene is large, and it takes a long time for these alleles to be taken over by new mutations. In addition, in the face of similar mutation rates, the lower prevalence of rare diseases implies a higher allele disappearance rate (negative selection) for these diseases than for common diseases. Both of these effects (reservoir effect and selection pressure) imply that after the population expansion, allelic spectra became diverse much more quickly for the rare diseases than the common. In the long run, however, it is expected that the spectra for both rare and common diseases will become equally diverse (Fig. 2B ). Reich and Lander estimate that an intermediate stage presently exists in the population, where rare diseases have very diverse allelic structure but the common disorders have simple structure. A prediction of this theory is that rare disorders will largely consist of recent alleles whereas common disorders will consist of old (ancestral) alleles.
ALLELIC STRUCTURE OF SIMPLE DISEASES
Since >1000 Mendelian (monogenic) disease genes have been identified, our understanding of their complexity is considerable. In general, rare diseases with strong negative selection exhibit very large allelic diversity (8) . An exception to the pattern of high allelic diversity for rare disorders is when these alleles also provide heterozygous advantage. One example is provided by the thalassemias, which confer resistance to malaria. Once arisen, the strong positive selective pressure conferred by these single alleles ensures their relatively rapid spread through the population. Another exception to the high allelic diversity of rare disorders occurs if a population bottleneck results in greatly simplified spectra. For example, among Finnish and Ashkenazi Jewish populations, there are numerous examples of disease where individual alleles show greatly elevated frequencies compared with other populations. Overall then, for monogenic disorders there is good agreement between the theoretical predictions of Reich and Lander (2) and the available data.
ALLELIC STRUCTURE OF COMPLEX DISEASES
For common complex disorders, there are relatively few data on the diversity of allelic spectra due to the difficulty in identifying the responsible genes. The few known examples, however, tend to support the interaction model and the CD/CV hypothesis, since most of these genes have a small number of common, disease-associated alleles (Table 1 ). With a couple of possible exceptions, the genes/loci listed in Table 1 have been confirmed in multiple studies and are unlikely to represent type 1 errors. It should be noted, however, that the listed genes may not be fully representative of common disease genes, since genes with a small number of common alleles would be easier to identify by association than genes with a large number of rare alleles.
Another valid test of the CD/CV hypothesis is to examine the genetic complexity of quantitative traits related to common disease, such as blood pressure, body mass index and plasma lipids. One well-studied group of phenotypes comprises the levels and compositions of plasma lipoproteins, which are strongly associated with coronary heart disease. With the exception of mutations of the LDL receptor that underlie familial hypercholesterolemia (a relatively common monogenic disorder), most of the known variations associated with the traits are due to a small number of common alleles (Table 1) .
A corollary of the CD/CV hypothesis is that each individual will carry susceptibility genes for numerous disorders. This point is difficult to examine systematically in humans, although, clearly, older individuals frequently suffer from a host of common maladies. A more convincing example is provided by surveying inbred mouse strains for differences in disease-related traits. Table 1 lists some common diseases and related traits differing between the two inbred strains DBA/2J and C57BL/6J. Many of these traits have been analyzed in genetic crosses between the two strains, and are known to be due to multiple quantitative trait loci (QTL). One might argue that, since the mice have been maintained by continuous brother-sister mating for many generations, numerous mutations have been fixed, and these are responsible for the trait differences. A counter argument to this, however, is the fact that a number of the loci observed in the DBA/2J Â C57BL/6J cross are also observed in crosses with other strains, and, in some cases, these loci are syntenic with human loci for the corresponding traits (9) .
Apart from these examples, the rapid fall-off in disease rates in relatives of affected observed for most common diseases argues for the interaction model and against the heterogeneity model. In addition, many common diseases exhibit a high ratio of relative risk for monozygotic twins to that for dizygotic twins, also consistent with the genetics of the multifactorial threshold model (2,10). However, there are exceptions. For example, the common disease familial combined hyperlipidemia (prevalence 1-2%) exhibits an apparent dominant mode of inheritance through many generations, yet is clearly very complex (11) . Furthermore, the inheritance of cancers is, in some ways, more consistent with a heterogeneity model (see below).
Other challenges to the CD/CV hypothesis, also in the area of cancer, are presented by the breast cancer genes BRCA1 and BRCA2 (12). These loci contribute to a relatively common genetic disorder, but have many different rare mutations, even in the Ashkenazi population (see above). In addition, even when the CD/CV hypothesis is true, disease genes may be dominated by a few alleles, but have large numbers of minor alleles. In the case of cystic fibrosis, 67% of disease alleles in the Caucasian population are accounted for by a single mutation. Nevertheless, the total number of known disease alleles exceeds 100 (8) .
DO ALL COMMON DISEASES HAVE A SIMILAR ALLELIC STRUCTURE?
The general allelic architecture of various diseases or classes of genes may differ depending on the biological mechanisms involved. Mitchison (13) has made the analogy between mutations in coding regions (hardware) and mutations in regulatory regions (software). He further divides genes into extrovert, concerned with the outside world (e.g. immunoglobulins and olfactory receptors) and the more numerous introvert genes, concerned with cellular homeostasis (e.g. transcription, signal transduction and neurotransmission). Mitchison suggests that for extrovert genes, hardware variation (coding regions) is more common, while for introvert genes, most genetic variation has mild effects and occurs in the software (regulatory regions). Many instances of promoter variation (software) are found in pharmacogenomics and psychiatry (14) . One example is provided by a 44 bp insertion/deletion polymorphism in the promoter region of the human serotonin transporter (5-HTT) gene. This polymorphism has been associated with affective illness and anxiety-related traits, and also alters 5-HTT gene expression, since the short promoter is less active than the long promoter. Another example of promoter polymorphism is found in the 5-lipoxygenase (5-LO) gene. This gene displays variations in the number of (G þ C)-rich Sp1 and Egr-1 transcription factorbinding sites, which influence promoter efficiency through methylation (15) . The resulting variations in 5-LO levels may be relevant to the inflammatory response in asthma (16) .
It is pertinent to note that whereas our understanding of the kinds of variations that occur in Mendelian diseases is extensive, our knowledge of the variations that explain common disease is very limited. Relevant to transcriptional regulation, one approach to the identification of common disease gene candidates is to survey cases and controls using expression array analysis. In this regard, it is noteworthy that about one-third of the known common disease genes (Table 1) affect expression levels (8) .
Interesting evidence that the inheritance of cancers is distinct from that of most common diseases has been provided by Risch (10) . With few exceptions, different cancers have roughly the same familial relative risk (FRR), although the FRR increases with early age of onset. Traditionally, most studies attribute a large environmental component to cancer. The relevant evidence includes such observations as dramatic shifts in cancer incidence due to population migrations. However, careful evaluation of twin and family studies suggest that genetics also plays a large part in cancer risk (10) . A key quantity is R MD , the FRR ratio between monozygotic (MZ) and dizygotic (DZ) twins. The idea is that MZ and DZ twins have a comparable sharing of environmental factors, so any difference in concordance rates between MZ and DZ twins must reflect genetic factors. For disease due to a single rare dominant gene, R MD ¼ 2, and for a recessive rare gene, R MD ¼ 4 but diminishes toward 2 if the allele is very common. For multiple loci, R MD can become very large. For most cancers, R MD $2, compared with much higher ratios for many complex diseases such as schizophrenia, multiple sclerosis, and autism. These data are consistent with either rare dominant alleles or additive gene effects for cancer, rather than an interactive, multigenic model.
LINKAGE DISEQUILIBRIUM
Related to the CV/CD hypothesis is the idea that diagnostic costs can be reduced to manageable levels using linkage disequilibrium. The idea here is that the great population expansion is sufficiently recent that large blocks of haplotypes are likely to be conserved between genomes. If true, this would greatly reduce the density of single-nucleotide polymorphisms (SNPs) required for association studies and the expense of genotyping. An implicit assumption of this approach is that common haplotypes are responsible for common diseases.
Estimates of the extent of LD have been obtained by sampling various restricted genomic regions (17), as well as over 51 autosomal regions spanning a total of 13 megabases (18). In addition, somatic cell genetics has been used to analyze LD over the entire chromosome 21 (19) . From LD sampling, the average distance over which useful LD was preserved was $50-60 kb. However, there was considerable variability, and in some loci, LD was found as far away as 500 kb, while in other regions, no useful disequilibrium was found. The chromosome 21 study found considerable linkage disequilibrium, with long blocks of conserved haplotypes. Interestingly, greater than 80% of the haplotype structure could be defined by less than 10% of the SNPs. Based on such studies, it appears that the extent of linkage disequilibrium in the genome will be region-and population-specific.
The dark side of linkage disequilibrium has been revealed by a recent study to identify genes on chromosome 5 involved in Crohn's disease (20) . Although a region of linkage disequilibrium associated with the disease was identified, a lack of recombination events within the relevant haplotype block precluded identification of the responsible gene. Thus, although the existence of large haplotype blocks is good news from the point-of-view of cheap diagnostics, it may hinder definitive identification of the responsible genes and any associated biological insights. In this situation, the use of alternate populations may come to the rescue, allowing subdivision of large regions of linkage disequilibrium. For narcolepsy, it was possible to identify a recombination event in a Japanese family that broke up a haplotype block in the HLA region, allowing finer mapping of the responsible gene (21) . Alternatively, scientists may have to rely on animal models, such as the mouse, to ultimately identify the causative gene.
THE FUTURE OF HUMAN GENETICS
Despite continued improvements in genotyping speed, the power of these technologies is not unlimited. At present, hopes are focused on exploiting the structure of the human population to realize the dream of individualized genotyping. This population structure, which results from its recent dramatic expansion, has been theorized to result in simple allelic spectra for common disease genes and considerable linkage disequilibrium. There is presently insufficient data to know whether these expectations will be realized, although there are promising hints.
Although particular alleles and haplotypes may be numerically rare in the population as a whole, it is nevertheless likely that each individual will harbor a significant number of such variants. In addition, estimates of gene mutation rates imply that each individual has about three de novo gene mutations within their genome. Thus, even if the interaction model proves true for most loci, personalized medicine will still benefit from a more individually tailored genotyping.
The distinctions between the interaction and genetic heterogeneity models can be restated using the following question: 'In the human population, would we rather know all rare 'severe' genetic mutations (e.g. nonsense, frameshift and nonsynonymous), or would we rather know all common variations?' With present limitations on the speed of genotyping and lack of knowledge of the genetic causation of common human disease, the best choice between these two alternatives is unclear. Of course, the optimal situation would be to know the answer to both questions. Thus, the need for ever more rapid genotyping and sequencing technologies is likely to continue for the foreseeable future.
